Transforming the Clinical Experience and Reducing Costs with Data & Analytics

November 17 - 19, 2019 | Omni Fort Worth, Fort Worth, TX

Rich Jolly

Vice President, Analytics & Strategy Avamere Health Services

Rich Jolly is VP of Analytics & Strategy for Avamere Health Services (a regional provider of post-acute care operating in 246 locations in 18 states with nearly 9,000 employees).  Rich has a diverse background with over 10 years of leadership in data science where he has developed and landed production machine learning systems and business intelligence dashboards.  In addition, Rich has over 10 years of leadership in strategy with Intel driving business and product plans where he was awarded the Intel Achievement Award for conception and planning of Intel Active Management Technology (AMT). Rich is a recognized expert in systems (complexity) science and has taught at the university level and written a book on the topic (‘Systems Thinking for Business’). Rich has a PhD and an MBA.  

NEW! Exclusive Q&A with Avamere's VP of Analytics & Strategy

NEW! Exclusive Q&A with Avamere's VP of Analytics & Strategy

View Content

Agenda Day 2: Monday, November 18, 2019

Monday, November 18th, 2019

2:30 PM Using Analytics to Transform the Patient Experience & Foster Innovative Care

As organizations become increasingly concerned with developing strategies to capitalize on the consumerization of healthcare, analytics has emerged as a powerful tool to better understand patient expectations as well as to determine which pain points are most intrinsically tied to overall patient satisfaction.

Gain insights into how:
•Incorporating patient scorecards to improve commercial excellence tracking
•Discrete data sets are being manipulated to create better context for compliance modeling 
•Deploying Patient Reported Outcome Measures (PROM’s) can lead to significantly improved outcomes under the value-based care model. 
•Fortifying strategic data governance frameworks has contributed to increased data sharing and use of HIE’s in genomic